Skip to main content
OpenTrials

Clinical trial condition

Dendritic Cell Sarcoma, Interdigitating

Explore clinical trials studying Dendritic Cell Sarcoma, Interdigitating. Study availability and eligibility vary by location and protocol.

228 public trials 29 recruiting studies
Refine in advanced search Browse all conditions

Dendritic Cell Sarcoma, Interdigitating trial results

Completed

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

NCT00006348

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +100 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States
  • Siouxland Hematology-Oncology Sioux City, Iowa, United States
View Trial Details
Completed

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer

NCT00053196

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +52 more
Locations
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • St. Francis Hospital Wilmington, Delaware, United States
View Trial Details
Completed

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

NCT01748721

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +103 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • University of California San Francisco Medical Center - Parnassus San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 20 locations
View Trial Details
Completed

Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation

NCT00080873

Conditions
Bone Marrow Diseases, Burkitt Lymphoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +56 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Stanford Comprehensive Cancer Center at Stanford University Medical Center Stanford, California, United States
View all 44 locations
View Trial Details
Completed

Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00134004

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +63 more
Locations
  • Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Hahnemann University Hospital Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia

NCT00324779

Conditions
Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +19 more
Locations
  • Kinderklinik - Universitaetsklinikum Aachen Aachen, Germany
  • Klinikum Augsburg Augsburg, Germany
  • Charite - Campus Charite Mitte Berlin, Germany
  • Helios Klinikum Berlin Berlin, Germany
View all 38 locations
View Trial Details

Related conditions